Hansen to acquire AorTx
Hansen Medical has signed a definitive agreement to acquire AorTx, of Redwood City, Calif., a developer of percutaneous, or catheter-based, valve technology.
The Mountain View, Calif.-based Hansen said the acquisition will allow the company to leverage its Sensei robotic catheter system, which is currently marketed for electrophysiology procedures, into the market for percutaneous heart valve therapy.
Hansen reported that the acquisition will include a closing payment of $5 million in its common stock and $5 million in cash. There are also possible milestone payments that total up to $15 million in Hansen’s common stock and $15 million in cash upon the achievement of regulatory clearances, revenue and partnering milestones.
The Mountain View, Calif.-based Hansen said the acquisition will allow the company to leverage its Sensei robotic catheter system, which is currently marketed for electrophysiology procedures, into the market for percutaneous heart valve therapy.
Hansen reported that the acquisition will include a closing payment of $5 million in its common stock and $5 million in cash. There are also possible milestone payments that total up to $15 million in Hansen’s common stock and $15 million in cash upon the achievement of regulatory clearances, revenue and partnering milestones.